MedTrace Logo

Enhanced Recovery After Minimally Invasive Pancreaticoduodenectomy

NCT02671357 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 210

Last updated 2020-03-26

No results posted yet for this study

Summary

This prospective observational cohort study aims to improve the postoperative course after minimally invasive pancreaticoduodenectomy (MIP) with stented pancreaticogastrostomy (sPG) for pancreatic head or peri-ampullary neoplasms. Patients are submitted to an enhanced recovery after surgery (ERAS) program with early enteral nutrition (EEN).

Conditions

  • Pancreatic Neoplasms; Periampullary Neoplasms

Interventions

PROCEDURE

ERAMIP

3D-LPD with stented umbrella-pancreaticogastrostomy \& Roux-en-Y reconstruction of the biliary limb of the hepatico-jejunostomy onto the efferent limb of the gastro-enterostomy (RY-GES)

Sponsors & Collaborators

  • University Hospital, Gasthuisberg

    lead OTHER

Principal Investigators

  • Baki Topal, MD, PhD · University Hospitals KU Leuven

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2019-06-30
Completion
2019-06-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02671357 on ClinicalTrials.gov